From the November 2022 issue of HealthCare Business News magazine
Future Outlook
In the coming years, market growth for both interventional and surgical X-ray equipment is forecast to be positive, following a year of market retraction in 2020. Beyond the pandemic, the main growth drivers will continue to be the growing burden of chronic diseases owing to changing lifestyles, and the rising need for cost-effective, minimally invasive interventional procedures. The rising prevalence of chronic conditions, such as cancer, heart disease, and others, and advances in minimally invasive, targeted treatments using imaging guidance continue to drive the market. Increasing competition from Asian manufacturers is increasing the affordability and adoption of image-guided therapy systems in emerging countries. The increased demand for complex neurology, oncology and cardiovascular procedures means that hospitals are increasingly prioritising advanced multidisciplinary equipment. Advanced features such as AI, dose management and treatment planning capabilities will increase the uptake of more high-end technology in developed countries. Within the mobile C-arm market, positive growth from 2021 onwards is attributed to the rising geriatric population with a high susceptibility to chronic conditions such as cardiovascular, orthopedic and respiratory diseases. This, alongside increasing patient awareness of the benefits of minimally invasive procedures, is expected to drive the market growth over the forecast period.
About the author: Bhvita Jani is a senior market analyst at Signify Research, an independent supplier of market intelligence and consultancy to the global healthcare technology industry. Its major coverage areas are healthcare IT, medical imaging and digital health. Clients include technology vendors, healthcare providers and payers, management consultants and investors. Signify Research is headquartered in Cranfield, U.K. To find out more visit www.signifyresearch.net
Back to HCB News
